16-23478401-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015044.4(GGA2):āc.1259A>Cā(p.Asp420Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000213 in 1,457,224 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015044.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GGA2 | NM_015044.4 | c.1259A>C | p.Asp420Ala | missense_variant | 13/17 | ENST00000309859.8 | |
GGA2 | XM_047433801.1 | c.1229A>C | p.Asp410Ala | missense_variant | 14/18 | ||
GGA2 | XM_047433802.1 | c.1148A>C | p.Asp383Ala | missense_variant | 13/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GGA2 | ENST00000309859.8 | c.1259A>C | p.Asp420Ala | missense_variant | 13/17 | 1 | NM_015044.4 | P1 | |
GGA2 | ENST00000567468.5 | c.624+8345A>C | intron_variant | 2 | |||||
GGA2 | ENST00000569182.1 | n.445A>C | non_coding_transcript_exon_variant | 4/5 | 4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000402 AC: 10AN: 248916Hom.: 0 AF XY: 0.0000298 AC XY: 4AN XY: 134450
GnomAD4 exome AF: 0.0000213 AC: 31AN: 1457224Hom.: 0 Cov.: 33 AF XY: 0.0000221 AC XY: 16AN XY: 724236
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 26, 2023 | The c.1259A>C (p.D420A) alteration is located in exon 13 (coding exon 13) of the GGA2 gene. This alteration results from a A to C substitution at nucleotide position 1259, causing the aspartic acid (D) at amino acid position 420 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at